BioTech Health XAugust 1, 2022 Biotech NewsKrystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial 3 minute read Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug… 0 Shares 0 0 0 0 0 0 0